1

Competitive Landscape: Takeda, VectivBio, Zealand Pharma & Others

News Discuss 
Explore the Short Bowel Syndrome market report, segmented by drug class (GLP-2, growth hormone, glutamine, others), distribution channel (hospital, retail), and geography—covering growth drivers, clinical trial pipelines, regional dynamics, and forecasts through 2030. https://www.datamintelligence.com/research-report/short-bowel-syndrome-market?dr

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story